Relationship of adiposity with arterial stiffness as mediated by adiponectin in older men and women: The Hoorn study

European Journal of Endocrinology

Volumn 160, Issue 3, 2009, Pages 387-395

  Sniijder, Marieke B ^a,b   Flyvbjerg, A ^c   Stehouwer, C D A ^d   Frystyk, J ^c   Henry, R M A ^d   Seidell, J C ^a,b   Heine, R J ^b   Dekker, J M ^b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN, HUMAN;

ABDOMINAL OBESITY; ADULT; AGED; AGING; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BRACHIAL ARTERY; CAROTID ARTERY; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FEMALE; FEMORAL ARTERY; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; ABDOMINAL FAT; ARTERY; BLOOD; CARDIOVASCULAR DISEASE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ABDOMINAL FAT; ADIPONECTIN; AGED; AGED, 80 AND OVER; AGING; ARTERIES; BODY COMPOSITION; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY;

EID: 62649132921     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0817     Document Type: Article

References (50)

1. Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong CP, Sellers TA, Lazovich D & Prineas RJ. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Archives of Internal Medicine 2000 160 2117-2128.
2. Westerhof N & O'Rourke MF. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. Journal of Hypertension 1995 13 943-952.
3. Ferreira I, Snijder MB, Twisk JW, van Mechelen W, Kemper HC, Seidell JC & Stehouwer CD. Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study Journal of Clinical Endocrinology and Metabolism 2004 89 2632-2639.
4. Snijder MB, Henry RM, Visser M, Dekker JM, Seidell JC, Ferreira I, Bouter LM, Yudkin JS, Westerhof N & Stehouwer CD. Regional body composition as a determinant of arterial stiffness in the elderly: the Hoorn Study. Journal of Hypertension 2004 22 2339-2347.
5. Lau DC, Dhillon B, Yan H, Szmitko PE & Verma S. Adipokines: molecular links between obesity and atheroslcerosis. American Journal of Physiology. Heart and Circulatory Physiology 2005 288 H2031-H2041.
6. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD & Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003 46 459-469.
7. Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ & Christiansen C. Central and peripheral fat mass have contrasting effect on the progression of aortic calcification in postmenopausal women. European Heart Journal 2003 24 1531-1537.
8. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Yudkin JS, Heine RJ, Nijpels G & Seidell JC. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care 2004 27 372-377.
9. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K & Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 2006 116 1784-1792.
10. Szmitko PE, Teoh H, Stewart DJ & Verma S. Adiponectin and cardiovascular disease: state of the art? American Journal of Physiology. Heart and Circulatory Physiology 2007 292 H1655-H1663.
11. Kozakova M, Muscelli E, Flyvbjerg A, Frystyk J, Morizzo C, Palombo C & Ferrannini E. Adiponectin and left ventricular structure and function in healthy adults. Journal of Clinical Endocrinology and Metabolism 2008 93 2811-2818.
12. Stork S, Bots ML, Angerer P, von Schacky C, Grobbee DE, Angermann CE & Seufert J. Low levels of adiponectin predict worsening of arterial morphology and function. Atherosclerosis 2007 194 147-153.
13. Araki T, Emoto M, Yokoyama H, Maeno T, Hatsuda S, Mori K, Koyama H, Shoji T, Inaba M & Nishizawa Y. The association of plasma adiponectin level with carotid arterial stiffness. Metabolism 2006 55 587-592.
14. Mahmud A & Feely J. Adiponectin and arterial stiffness. American Journal of Hypertension 2005 18 1543-1548.
15. Tentolouris N, Doulgerakis D, Moyssakis I, Kyriaki D, Makrilakis K, Kosmadakis G, Stamatiadis D, Katsilambros N & Stathakis C. Plasma adiponectin concentrations in patients with chronic renal failure: relationship with metabolic risk factors and ischemic heart disease. Hormone and Metabolic Research 2004 36 721-727.
16. Mooy JM, Grootenhuis PA, de Vries H, Valkenburg HA, Bouter LM, Kostense PJ & Heine RJ. Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study. Diabetes Care 1995 18 1270-1273.
17. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM & Heine RJ. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. Journal of the American Medical Association 2001 285 2109-2113.
18. Frystyk J, Tarnow L, Krarup Hansen T, Parving HH & Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005 48 1911-1918.
19. Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Westerhof N & Stehouwer CD. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension 2004 43 176-181.
20. Henry RM, Kostense PJ, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Kamp O, Westerhof N, Bouter LM & Stehouwer CD. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 2003 107 2089-2095.
21. Kelly R & Fitchett D. Noninvasive determination of aortic input impedance and external left ventricular power output: a validation and repeatability study of a new technique. Journal of the American College of Cardiology 1992 20 952-963.
22. Van Bortel LM, Balkestein EJ, van der Heijden-Spek JJ, Vanmolkot FH, Staessen JA, Kragten JA, Vredeveld JW, Safar ME, Struijker Boudier HA & Hoeks AP. Non-invasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking. Journal of Hypertension 2001 19 1037-1044.
23. Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, Kaiser DR & Thuillez C. Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. American Journal of Hypertension 2002 15 445-452.
24. Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, Bouter LM & Stehouwer CD. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney International 2002 62 1402-1407.
25. Spijkerman AM, Adriaanse MC, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM & Heine RJ. Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care 2002 25 1784-1789.
26. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N & Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine 1999 130 461-470.
27. Mazzali G, Di Francesco V, Zoico E, Fantin F, Zamboni G, Benati C, Bambara V, Negri M, Bosello O & Zamboni M. Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women. American Journal of Clinical Nutrition 2006 84 1193-1199.
28. Nemet D, Wang P, Funahashi T, Matsuzawa Y, Tanaka S, Engelman L & Cooper DM. Adipocytokines, body composition, and fitness in children. Pediatric Research 2003 53 148-152.
29. Zoico E, Di Francesco V, Mazzali G, Vettor R, Fantin F, Bissoli L, Guariento S, Bosello O & Zamboni M. Adipocytokines, fat distribution, and insulin resistance in elderly men and women. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2004 59 M935-M939.
30. Cote M, Mauriege P, Bergeron J, Almeras N, Tremblay A, Lemieux I & Despres JP. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. Journal of Clinical Endocrinology and Metabolism 2005 90 1434-1439.
31. Kwon K, Jung SH, Choi C & Park SH. Reciprocal association between visceral obesity and adiponectin in healthy premenopausal women. International Journal of Cardiology 2005 101 385-390.
32. Buemann B, Astrup A, Pedersen O, Black E, Holst C, Toubro S, Echwald S, Holst JJ, Rasmussen C & Sorensen TI. Possible role of adiponectin and insulin sensitivity in mediating the favorable effects of lower body fat mass on blood lipids. Journal of Clinical Endocrinology and Metabolism 2006 91 1698-1704.
33. Tanko LB, Bruun JM, Alexandersen P, Bagger YZ, Richelsen B, Christiansen C & Larsen PJ. Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation 2004 110 2246-2252.
34. Ritland LM, Alekel DL, Matvienko OA, Hanson KB, Stewart JW, Hanson LN, Reddy MB, Van Loan MD & Genschel U. Centrally located body fat is related to appetitive hormones in healthy postmenopausal women. European Journal of Endocrinology 2008 158 889-897.
35. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE & Goldstein BJ. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. Journal of Clinical Endocrinology and Metabolism 2002 87 5662-5667.
36. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A & Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. Journal of Clinical Endocrinology and Metabolism 2007 92 571-576.
37. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, Danesh J & Whincup PH. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 2006 114 623-629.
38. Kanaya AM, Wassel Fyr C, Vittinghoff E, Havel PJ, Cesari M, Nicklas B, Harris T, Newman AB, Satterfield S & Cummings SR. Serum adiponectin and coronary heart disease risk in older Black and White Americans. Journal of Clinical Endocrinology and Metabolism 2006 91 5044-5050.
39. Lawlor DA, Smith GD, Ebrahim S, Thompson C & Sattar N. Plasma adiponectin levels are associated with insulin resistance but do not predict future risk of coronary heart disease in women. Journal of Clinical Endocrinology and Metabolism 2005 90 5677-5683.
40. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T & Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. Journal of the American Society of Nephrology 2002 13 134-141.
41. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A & Hildebrandt P. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005 112 1756-1762.
42. George J, Patal S, Wexler D, Sharabi Y, Peleg E, Kamari Y, Grossman E, Sheps D, Keren G & Roth A. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 2006 92 1420-1424.
43. Pilz S, Mangge H, Wellnitz B, Seelhorst U, Winkelmann BR, Tiran B, Boehm BO & Marz W. Adiponectin and mortality in patients undergoing coronary angiography. Journal of Clinical Endocrinology and Metabolism 2006 91 4277-4286.
44. Laughlin GA, Barrett-Connor E, May S & Langenberg C. Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. American Journal of Epidemiology 2007 165 164-174.
45. Wannamethee SG, Whincup PH, Lennon L & Sattar N. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Archives of Internal Medicine 2007 167 1510-1517.
46. Dekker JM, Funahashi T, Nijpels G, Pilz S, Stehouwer CD, Snijder MB, Bouter LM, Matsuzawa Y, Shimomura I & Heine RJ. Prognostic value of adiponectin for cardiovascular disease and mortality. Journal of Clinical Endocrinology and Metabolism 2008 93 1489-1496.
47. Teoh H, Strauss MH, Szmitko PE & Verma S. Adiponectin and myocardial infarction: a paradox or a paradigm? European Heart Journal 2006 27 2266-2268.
48. Rathmann W & Herder C. Adiponectin and cardiovascular mortality: evidence for 'reverse epidemiology'. Hormone and Metabolic Research 2007 39 1-2.
49. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T & Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 1595-1599.
50. Yamamoto Y, Hirose H, Saito I, Nishikai K & Saruta T. Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. Journal of Clinical Endocrinology and Metabolism 2004 89 87-90.